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We read with interest the article by Gogos and colleagues 
in a previous issue of Critical Care reporting that there are 
major diﬀ   erences in the early status of the innate and 
adaptative immune responses between sepsis and severe 
sepsis/shock in relation to the underlying type of infec  tion 
[1]. In patients with acute pyelonephritis and intra-
abdominal infection, expression of HLA-DR on mono-
cytes was signiﬁ   cantly decreased among patients with 
severe sepsis/shock compared with among patients only 
suﬀ   ering sepsis. Th  is diﬀ   erence was related to an un-
favourable outcome in patients with acute pyelo  nephritis.
Th   e authors considered the decrease of CD14/HLA-DR 
co-expression to be an index of immunoparalysis and bad 
prognosis [1]. An altered expression of HLA-DR on the 
monocyte surface, however, is not synonymous with a 
global downregulation of cellular reactivity. Th  e term 
cellular reprogramming thus appears the most appro-
priate to deﬁ  ne the events occurring among circulating 
monocytes and other immune cells during severe sepsis/
shock [2]. In addition, a growing set of evidence un  doub-
tedly indicates that, despite the Toll-like receptor/IL-1 
receptor-associated kinase/NF-κB pathway being blocked, 
other alternative signals are active simul  taneously in 
septic patients [3-5].
Recently, we analysed a cohort of 17 patients who met 
the diagnostic criteria for sepsis [6] (see Figure 1 overleaf). 
Our ﬁ  ndings demonstrated that these patients showed 
reduced responsiveness to a lipopolysaccharide challenge 
(which is called endotoxin tolerance) but their monocytes 
were not paralysed. As Figure 1a to 1f shows, despite an 
evident downregulation of TNFα production after ex vivo
lipopolysaccharide challenge, septic patients’ monocytes 
exhibited high levels of key genes from several pathways 
(NF-κB2/p100, NF-κB-inducing kinase, lymphotoxin β-
receptor, v-rel reticuloendotheliosis viral oncogene 
homo  logue A (p65) and serine/threonine protein kinase). 
Th  ese data suggest an alternative activation of their 
innate immune cells as occurs in endotoxin tolerance. In 
contrast, we observed a negative regulation of several 
genes of lymphocytes such as T-cell antigen receptor, 
linked for activation of T cells, and ΔCD3–TCR complex 
(Figure 1g to 1i). Th   ese results are in line with previous 
observations that patients who suﬀ  er from an endotoxin 
tolerance have an impaired immune adaptative system 
[3,4].
Th  e analysis of several parameters of the immune 
response (expression of HLA-DR on monocytes, and 
subsets of lymphocytes) seems unsuitable to characterise 
the complexity of septic patients’ immunological status, 
because it rapidly changes over time. Identiﬁ  cation  of 
polymorphic genome variations that may inﬂ  uence 
susceptibility to sepsis and alter its outcome, however, is 
a new approach in sepsis research.
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Figure 1. Alternative responses are activated in monocytes from septic patients. (a) to (f) Monocytes from septic patients (age 51 ± 12 years, 
mean ± standard deviation), who met the diagnostic criteria for sepsis, were isolated (n = 17). Blood samples were taken when they met the 
sepsis criteria for the fi  rst time. The following exclusion criteria were imposed: malignancy and chronic infl  ammatory diseases, treatments with 
steroids or immunosuppressive drugs during the past month, hepatic failure (serum aspartate aminotransferase and/or alanine aminotransferase 
level >100 IU/l; prothrombin time <60%, total bilirubin level >60 μmol/l), renal insuffi   ciency (plasma creatinine level >200 μmol/l), AIDS, virus B or 
virus C hepatitis, gestation, and age >70 years. Total RNA was then isolated and the levels of (a) TNFα, (b) NF-κB2/p100, (c) NF-κB-inducing kinase 
(NIK), (d) lymphotoxin β-receptor (LTBR), (e) v-rel reticuloendotheliosis viral oncogene homologue A (p65) (RelA) and (f) serine/threonine protein 
kinase (AKT) were determined by real-time quantitative PCR. (a) In the case of TNFα, induction levels were also analysed when monocytes were 
challenged with lipopolysaccharide (LPS) (10 ng/ml) for 3 hours, ex vivo. (g) to (i) Lymphocytes from septic patients were isolated (n = 17). Total RNA 
was then isolated and the levels of (g) T-cell antigen receptor (TCR), (h) linked for activation of T cells (LAT) and (i) ΔCD3–TCR complex (CD3D) were 
determined by real-time quantitative PCR. The fold induction with respect to the basal is depicted. *P <0.01 septic phase versus recovery phase 
(1 month afterwards).
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